{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:13:00Z","timestamp":1763035980284},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2005,2,12]],"date-time":"2005-02-12T00:00:00Z","timestamp":1108166400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1007\/s00198-005-1844-1","type":"journal-article","created":{"date-parts":[[2005,2,11]],"date-time":"2005-02-11T09:50:08Z","timestamp":1108115408000},"page":"1368-1374","source":"Crossref","is-referenced-by-count":75,"title":["The contribution of serum osteoprotegerin to bone mass and vertebral fractures in postmenopausal women"],"prefix":"10.1007","volume":"16","author":[{"given":"Pedro","family":"Mezquita-Raya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"de la Higuera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego Fern\u00e1ndez","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Estrella","family":"Ruiz-Requena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"de Dios Luna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Escobar-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Mu\u00f1oz-Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,2,12]]},"reference":[{"key":"1844_CR1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1359\/jbmr.2000.15.1.2","volume":"15","author":"Hofbauer","year":"2000","unstructured":"Hofbauer LC, Khosla S, Dunstan CR, Lacey D, Boyle WJ, Riggs BL (2000) The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 15:2\u201312","journal-title":"J Bone Miner Res"},{"key":"1844_CR2","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1210\/endo.139.3.5837","volume":"139","author":"Yasuda","year":"1998","unstructured":"Yasuda H, Shima N, Nakagawa N et al (1998) Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG\/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139:1329-1337","journal-title":"Endocrinology"},{"key":"1844_CR3","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S8756-3282(98)00141-0","volume":"23","author":"Akatsu","year":"1998","unstructured":"Akatsu T, Murakami T, Ono K et al (1998) Osteoclastogenesis inhibitory factor exhibits hypocalcemic effects in normal mice and in hypercalcemic nude mice carrying tumors associated with humoral hypercalcemia of malignancy. Bone 23:495-498","journal-title":"Bone"},{"key":"1844_CR4","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1359\/jbmr.2001.16.2.348","volume":"16","author":"Bekker","year":"2001","unstructured":"Bekker PJ, Holloway D, Nakanishi A, Arrighi HM, Leese PT, Dunstan CR (2001) The effect of a single dose of osteoprotegerin in postmenopausal women. J Bone Miner Res 16:348-360","journal-title":"J Bone Miner Res"},{"key":"1844_CR5","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1359\/JBMR.040305","volume":"19","author":"Bekker","year":"2004","unstructured":"Bekker PJ, Holoway DL, Rasmussen AS, et al (2004) A single-dose placebo-controlled study of AMG 162, fully human monoclonal antibody to RANKL, in postmenopausal women. J Bone Miner Res 19:1059\u20131066","journal-title":"J Bone Miner Res"},{"key":"1844_CR6","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1210\/endo.140.9.7131","volume":"140","author":"Hofbauer","year":"1999","unstructured":"Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Spelsberg TC, Riggs BL (1999) Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. Endocrinology 140:4367-4370","journal-title":"Endocrinology"},{"key":"1844_CR7","first-page":"829","volume":"977","author":"Schevde","year":"2000","unstructured":"Schevde NK, Bendixen A, Dienger KM, Pike JW (2000) Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression. Proc Natl Acad Sci USA 977:829\u2013834","journal-title":"Proc Natl Acad Sci USA"},{"key":"1844_CR8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","volume":"89","author":"Simonet","year":"1997","unstructured":"Simonet WS, Lacey DL, Dunstan CR et al (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309-319","journal-title":"Cell"},{"key":"1844_CR9","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1172\/JCI200317215","volume":"111","author":"Eghbali-Fatourechi","year":"2003","unstructured":"Eghbali-Fatourechi G, Khosla S, Sanyal A, Boyle WJ, Lacey DL, Riggs BL (2003) Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest 111:1221\u20131230","journal-title":"J Clin Invest"},{"key":"1844_CR10","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1359\/jbmr.1999.14.4.518","volume":"14","author":"Yano","year":"1999","unstructured":"Yano K, Tsuda E, Washida N et al (1999) Immunological characterization of circulating osteoprotegerin\/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis. J Bone Miner Res 14:518\u2013527","journal-title":"J Bone Miner Res"},{"key":"1844_CR11","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s001980200045","volume":"13","author":"Khosla","year":"2002","unstructured":"Khosla S, Arrighi HM, Melton III LJ et al (2002) Correlates of osteoprotegerin levels in women and men. Osteoporos Int 13:394\u2013399","journal-title":"Osteoporos Int"},{"key":"1844_CR12","first-page":"631","volume":"86","author":"Browner","year":"2001","unstructured":"Browner WS, Lui LY, Cummings SR (2001) Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women. J Clin Endocrinol Metab 86:631\u2013637","journal-title":"J Clin Endocrinol Metab"},{"key":"1844_CR13","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.1210\/jc.2002-020396","volume":"87","author":"Rogers","year":"2002","unstructured":"Rogers A, Saleh G, Hannon RA, Greenfield D, Eastell R (2002) Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women. J Clin Endocrinol Metab 87:4470\u20134475","journal-title":"J Clin Endocrinol Metab"},{"key":"1844_CR14","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S8756-3282(03)00090-5","volume":"32","author":"Kudlacek","year":"2004","unstructured":"Kudlacek S, Schneider B, Woloszczuk W, Pietschmann P, Willvonseder R (2004) Serum levels of osteoprotegerin increase with age in a healthy adult population. Bone 32:681\u2013686","journal-title":"Bone"},{"key":"1844_CR15","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1001\/jama.291.9.1108","volume":"291","author":"Schett","year":"2004","unstructured":"Schett G, Stefan K, Redlich K et al (2004) Soluble RANKL and risk of nontraumatic fracture. JAMA 291:1108\u20131113","journal-title":"JAMA"},{"key":"1844_CR16","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00198-003-1550-9","volume":"15","author":"Pennisi","year":"2004","unstructured":"Pennisi P, Signorelli SS, Riccobene S et al (2004) Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels. Osteoporos Int 15:389\u2013395","journal-title":"Osteoporos Int"},{"key":"1844_CR17","first-page":"757","volume":"10","author":"Rinaldi","year":"2001","unstructured":"Rinaldi S, D\u00e9chaud H, Biessy C et al (2001) Reliability and validity of commerciallyavailable, direct radioimmunoassays for measurements of blood androgens and estrogens in postmenopausal women. Cancer Epidemiol Biomark Prev 10:757\u2013765","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1844_CR18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/BF01623463","volume":"7","author":"Diaz","year":"1997","unstructured":"Diaz Curiel M, Carrasco de la Pe\u00f1a JL, Honorato Perez J, Perez Cano R, Rapado A, Ruiz Martinez I (1997) Study of bone mineral density in lumbar spine and femoral neck in a Spanish population. Multicentre Research Project on Osteoporosis. Osteoporos Int 7:59\u201364","journal-title":"Osteoporos Int"},{"key":"1844_CR19","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1210\/jcem-70-4-1202","volume":"70","author":"Orwoll","year":"1990","unstructured":"Orwoll ES, Oviatt SK, Mann T (1990) The impact of osteophytic and vascular calcifications on vertebral mineral density measurements in men. J Clin Endocrinol Metab 70:1202\u20131207","journal-title":"J Clin Endocrinol Metab"},{"key":"1844_CR20","unstructured":"Report of a WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. World Health Organ Tech Rep Ser 843:1\u2013129"},{"key":"1844_CR21","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1359\/jbmr.2000.15.4.763","volume":"15","author":"Cook","year":"2000","unstructured":"Cook GJ, Lodge MA, Blake GM, Marsden PK, Fogelman I (2000) Differences in skeletal kinetics between vertebral and humeral bone measured by 18Ffluoride positron emission tomography in postmenopausal women. J Bone Miner Res 15:763\u2013769","journal-title":"J Bone Miner Res"},{"key":"1844_CR22","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1210\/jc.2003-030486","volume":"88","author":"Naylor","year":"2003","unstructured":"Naylor KE, Rogers A, Fraser RB, Hall V, Eastell R, Blumsohn A (2003) Serum osteoprotegerin as a determinant of bone metabolism in a longitudinal study of human pregnancy and lactation. J Clin Endocrinol Metab 88:5361\u20135365","journal-title":"J Clin Endocrinol Metab"},{"key":"1844_CR23","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1359\/jbmr.2002.17.11.1961","volume":"17","author":"Hegedus","year":"2002","unstructured":"Hegedus D, Ferencz V, Lakatos PL et al (2002) Decreased bone density, elevated serum osteoprotegerin, and b-cross-laps in Wilson disease. J Bone Miner Res 17:1961\u20131967","journal-title":"J Bone Miner Res"},{"key":"1844_CR24","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0168-8278(02)00435-X","volume":"38","author":"Szalay","year":"2003","unstructured":"Szalay F, Hegedus D, Lakatos PL et al (2003) High serum osteoprotegerin and low RANKL in primary biliary cirrhosis. J Hepatol 38:395\u2013400","journal-title":"J Hepatol"},{"key":"1844_CR25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.1365-2265.2003.01969.x","volume":"60","author":"Hofbauer","year":"2004","unstructured":"Hofbauer LC, Schoppet M, Sch\u00fcller P, Viereck V, Michael Christ M (2004) Effects of oral contraceptives on circulating osteoprotegerin and soluble RANK ligand serum levels in healthy young women. Clin Endocrinol 60:14\u2013219","journal-title":"Clin Endocrinol"},{"key":"1844_CR26","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S8756-3282(02)00953-5","volume":"32","author":"Bord","year":"2003","unstructured":"Bord S, Ireland DC, Beavan SR, Compston JE (2003) The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts. Bone 32:136\u2013141","journal-title":"Bone"},{"key":"1844_CR27","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1530\/eje.0.1450199","volume":"145","author":"Seck","year":"2001","unstructured":"Seck T, Diel I, Bismar H, Ziegler R, Pfeilschifter J (2001) Serum parathyroid hormone, but no menopausal status, is associated with the expression of osteoprotegerin and RANKL mRNA in human bone samples. Eur J Endocrinol 145:199\u2013205","journal-title":"Eur J Endocrinol"},{"key":"1844_CR28","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1210\/edrv.23.3.0465","volume":"23","author":"Riggs","year":"2002","unstructured":"Riggs BL, Sundeep K, Melton LJ III (2002) Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 23:279\u2013302","journal-title":"Endocr Rev"},{"key":"1844_CR29","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s001980070088","volume":"11","author":"Looker","year":"2000","unstructured":"Looker AC, Bauer DC, Chesnut CH III, et al (2000) Clinical use of biochemical markers of bone remodelling: current status and future directions. Osteoporosis Int 11:467\u2013480","journal-title":"Osteoporosis Int"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-005-1844-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-005-1844-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-005-1844-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T11:03:55Z","timestamp":1558609435000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-005-1844-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2,12]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["1844"],"URL":"https:\/\/doi.org\/10.1007\/s00198-005-1844-1","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2,12]]}}}